Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 1—January 2022

Effects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong

Susan S. ChiuComments to Author , Benjamin J. Cowling, J.S. Malik Peiris, Eunice L.Y. Chan, Wilfred H.S. Wong, and Kwok Piu Lee
Author affiliations: The University of Hong Kong, Hong Kong, China (S.S. Chiu, B.J. Cowling, J.S. Malik Peiris, E.L.Y. Chan, W.H.S. Wong); Pamela Youde Nethersole Eastern Hospital, Hong Kong (K. Piu Lee)

Main Article

Table 2

Relative reductions in incidence rates of pediatric hospitalizations during period of NPI and incidence rate ratio during school reopenings compared with school closure periods, Hong Kong Island, January 2017–January 2021*

Virus Relative reduction, % (95% CI)† Incidence rate ratio (95% CI)‡
Influenza A 99 (98–100) NE
Influenza B 99 (97–100) NE
Respiratory syncytial virus 98 (97–99) NE
Adenovirus 85 (80–88) 1.27 (0.85–1.89)
Parainfluenza types 1–4 96 (95–97) 1.08 (0.85–1.69)
Human metapneumovirus 98 (95–99) NE
Rhinovirus/enterovirus 87 (85–89) 1.72 (1.37–2.17)

*NE, not estimated because <10 hospitalizations with the given virus were recorded during the NPI period; NPI, nonpharmaceutical intervention. †Estimated as 1 minus the incidence rate ratio in a Poisson regression model for virus-specific hospitalization rates, adjusted for age and calendar time, comparing the period February 2020–January 2021 (NPI period) with January 2016–2020. ‡Estimated in a Poisson regression model for virus-specific hospitalization rates, comparing the period when schools were reopened with infection control measures versus when they were closed during 2020–21, adjusted for the overall risk reduction during the NPI period as well as for age and calendar time. An incidence rate ratio >1 indicates an increased rate during the school resumption period and vice versa.

Main Article

Page created: November 10, 2021
Page updated: December 20, 2021
Page reviewed: December 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.